ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 108 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $966,063 | +193.6% | 47,148 | +184.7% | 0.00% | +100.0% |
Q2 2023 | $329,067 | +37.8% | 16,561 | +35.7% | 0.00% | 0.0% |
Q4 2022 | $238,774 | -37.3% | 12,201 | -48.9% | 0.00% | -50.0% |
Q3 2022 | $381,000 | -14.4% | 23,875 | -14.9% | 0.00% | 0.0% |
Q1 2022 | $445,000 | -51.2% | 28,056 | -32.8% | 0.00% | 0.0% |
Q4 2021 | $912,000 | +8.6% | 41,771 | +120.7% | 0.00% | -60.0% |
Q1 2021 | $840,000 | -27.1% | 18,923 | -9.9% | 0.01% | -44.4% |
Q4 2020 | $1,152,000 | +53.2% | 21,010 | -36.1% | 0.01% | -10.0% |
Q3 2020 | $752,000 | -37.7% | 32,888 | -43.0% | 0.01% | -50.0% |
Q2 2020 | $1,208,000 | +175.8% | 57,715 | +199.6% | 0.02% | +566.7% |
Q4 2019 | $438,000 | +8.7% | 19,262 | -44.3% | 0.00% | -25.0% |
Q3 2019 | $403,000 | -30.9% | 34,578 | -11.0% | 0.00% | -33.3% |
Q2 2019 | $583,000 | -1.9% | 38,864 | +14.8% | 0.01% | 0.0% |
Q1 2019 | $594,000 | -15.5% | 33,856 | -28.6% | 0.01% | -25.0% |
Q4 2018 | $703,000 | +154.7% | 47,419 | +323.4% | 0.01% | +166.7% |
Q3 2018 | $276,000 | – | 11,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |